AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENTTransaction Bonus Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This AMENDMENT NO. 1 TO TRANSACTION BONUS AGREEMENT (this “Amendment”) is entered into as of April 12, 2013 by and between ANIP Acquisition Company, a Delaware corporation (the “Company”), and James Marken (the “Executive”).
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Georgia
THIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is made and entered into this 11 day of April, 2013, by and between ANIP ACQUISITION COMPANY, a Delaware corporation (“Borrower”) with its chief executive office and principal place of business at 210 Main Street, Baudette, Minnesota 56623, and ALOSTAR BANK OF COMMERCE, a state banking institution incorporated or otherwise organized under the laws of the State of Alabama (together with its successors and assigns, “Lender”) with an office at 3630 Peachtree Road, N.E., Suite 1050, Atlanta, Georgia 30326.
AMENDMENT NO. 2 TO TRANSACTION BONUS AGREEMENTTransaction Bonus Agreement • April 26th, 2013 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This AMENDMENT NO. 2 TO TRANSACTION BONUS AGREEMENT (this “Amendment”) is entered into as of April 12, 2013 by and between ANIP Acquisition Company, a Delaware corporation (the “Company”), and Arthur Przybyl (the “Executive”).
